Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans

Aruna Vedala; Wei Wang; Richard A. Neese; Mark P. Christiansen; Marc Hellerstein

doi:10.1194/jlr.m600200-jlr200

Related publications

Article1996

Regulation of Hepatic De Novo Lipogenesis in Humans

Marc Hellerstein, Jean‐Marc Schwarz, Richard A. Neese

Article2020

De novo lipogenesis is essential for platelet production in humans

Kenneth L. Kelly, William J. Reagan, Gabriele E. Sonnenberg, Michelle Clasquin, Katherine Hales, Shoh Asano, Paul A. Amor, Santos Carvajal‐Gonzalez, Norimitsu Shirai, Marcy Matthews, Kelvin W. Li, Marc Hellerstein, Nicholas B. Vera, Trenton T. Ross, Gregg D. Cappon, Arthur Bergman, Clare Buckeridge, Zhongyuan Sun, Enida Ziso Qejvanaj, Theodore J. Schmahai, David A. Beebe, Jeffrey A. Pfefferkorn, William P. Esler

Article1991

Measurement of de novo hepatic lipogenesis in humans using stable isotopes.

Marc Hellerstein, Mads Christiansen, S. Kaempfer, C. Kletke, Kenneth K. Wu, Jessica Reid, Kathleen Mulligan, N. S. Hellerstein, C.H.L. Shackleton

Article1999

De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption

Scott Q. Siler, Richard A. Neese, Marc Hellerstein

Article2018

Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans

Carine Beysen, Marcella Ruddy, Aubrey Stoch, Lori Mixson, Kimberly Rosko, Timothy Riiff, Scott Turner, Marc Hellerstein, Elizabeth J. Murphy